SEC Form 4 · accession 0001140361-16-058669
BioRestorative Therapies, Inc. · BRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John M Desmarais
Director · 10% Owner
Period of report
Mar 18, 2016
Accepted (ET)
Mar 22, 2016 · 11:19 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001505497
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 18, 2016 | P | 250,000 | $4.00 | A | 375,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant | $5.00 | Mar 18, 2016 | P | 250,000 | A | Mar 18, 2016 | Mar 18, 2021 | Common Stock | 250,000 | 250,000 | D |
| Warrant | $4.50 | Mar 18, 2016 | P | 444,444 | A | Mar 18, 2016 | Nov 18, 2016 | Common Stock | 444,444 | 444,444 | D |
| Warrant | $5.00 | Mar 18, 2016 | P | 400,000 | A | Mar 18, 2016 | Mar 18, 2017 | Common Stock | 400,000 | 400,000 | D |
| OptionF1 | $4.40 | holding | — | — | — | — | Dec 1, 2025 | Common Stock | 15,000 | 15,000 | D |
| Warrant | $5.00 | holding | — | — | — | Dec 17, 2015 | Nov 17, 2020 | Common Stock | 125,000 | 125,000 | D |
Explanation of responses
- F1The option vests to the extent of 5,000 shares on each of December 1, 2016, 2017 and 2018.